Cargando…
Radiosynthesis and preclinical evaluation of [(11)C]prucalopride as a potential agonist PET ligand for the 5-HT(4) receptor
BACKGROUND: Serotonin 5-HT(4) receptor (5-HT(4)-R) agonists are potential therapeutic agents for enterokinetic and cognitive disorders and are marketed for treatment of constipation. The aim of this study was to develop an agonist positron emission tomography (PET) ligand in order to label the activ...
Autores principales: | Buiter, Hans JC, Windhorst, Albert D, Huisman, Marc C, De Maeyer, Joris H, Schuurkes, Jan AJ, Lammertsma, Adriaan A, Leysen, Josée E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623622/ https://www.ncbi.nlm.nih.gov/pubmed/23557209 http://dx.doi.org/10.1186/2191-219X-3-24 |
Ejemplares similares
-
[(11)C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors
por: Buiter, Hans JC, et al.
Publicado: (2013) -
Reproducible Analysis of Rat Brain PET Studies Using an Additional [(18)F]NaF Scan and an MR-Based ROI Template
por: Buiter, Hans J. C., et al.
Publicado: (2012) -
Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010) -
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders
por: Tack, J, et al.
Publicado: (2012) -
Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI
por: Rami-Mark, Christina, et al.
Publicado: (2015)